Medtronic, Inc. has just submitted the final pre-market approval documents to the FDA for its Talent™ Thoracic Stent Graft System. At the present time there is no evidence to expect that the FDA would create any hurdles for the company to commercially market and sell its endovascular system for descending thoracic aneurysms.
From the press release:
Minimally invasive therapies, such as endovascular stent grafting, provide potential benefits including reduced surgical morbidity, reduced hospital stay, and an improved quality of life. The procedure involves threading the stent graft through a small opening in the femoral artery of the leg. The stent graft is advanced under fluoroscopic guidance to the site of the thoracic aortic aneurysm, where it is then positioned and deployed from the delivery system. Once deployed, the stent graft expands to fit snugly within the diameter of the aorta, providing a new path for the blood flow.
Medtronic has been at […]
Published by Michael
Continue reading: Talent™ Thoracic Stent Graft System
Related with "Talent™ Thoracic Stent Graft System"
CYPHER® Sirolimus Eluting Coronary Stent …
CYPHER® Sirolimus Eluting Coronary Stent ...[...]
CYPHER® Sirolimus Eluting Coronary Stent Had …
CYPHER® Sirolimus Eluting Coronary Stent Had ...[...]
Bioabsorbable Stents: So Far So Good
Most people don’t like the idea of having a chunk of metal sitting in their body for the rest of one’s life, so the “ideal” for any medical device is to make it bioabsorbable. Its only a matter of time before the degradable-craze hits the stent market, and Abbott[...]
Stents take a hit
From the ACC meetings, the results that were supposed to be released tomorrow were leaked early: For patients with stable coronary artery disease, treatment with angioplasty and bare-metal stents does not reduce the risk of heart attack or a composite of death, heart attack and stroke. Let’s see if this study will[...]
There is no “one-tier” system
retired doc with more insight, as always: Dr. Brett does not elaborate on what the process would be to decide which interventions are or are not effective but one can assume that would not be done by the individual physician in consultation with the individual patient.Those decisions would be made by[...]
